Evoke Pharma, Inc. (EVOK)

5.52 +0.54 (+10.84%) At close: 04:00PM EST

Evoke Pharma, Inc.

420 Stevens Avenue
Suite 370
Solana Beach, CA 92075
United States
858 345 1494
https://www.evokepharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 4

Key executives

Name	Title	Pay	Exercised	Year born
Mr. David A. Gonyer	Co-Founder, CEO, Pres & Director	737.24k	N/A	1964
Mr. Matthew J. D'Onofrio	Co-Founder, Chief Bus. Officer, Exec. VP, Treasurer & Sec.	524.45k	N/A	1970
Dr. Marilyn R. Carlson	Chief Medical Officer	491.69k	N/A	1948
Mr. Christopher Quesenberry	Chief Commercial Officer - Gimoti (TM)	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Corporate governance

Evoke Pharma, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.